Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-1997 | 05-1997 | 02-1997 | 11-1996 | 08-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,156 | 221 | 7,254 | 4,729 | 4,823 |
| Depreciation Amortization | 2,934 | 1,469 | 4,955 | 3,002 | 2,067 |
| Other Working Capital | 5,256 | 6,651 | -12,303 | -8,020 | -5,765 |
| Other Operating Activity | 212 | -35 | 301 | 486 | 744 |
| Operating Cash Flow | $9,558 | $8,306 | $207 | $197 | $1,869 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,815 | -1,469 | -16,747 | -15,423 | -14,771 |
| Net Acquisitions | 0 | 0 | 2,868 | 3,150 | -12,631 |
| Other Investing Activity | -12,595 | -12,821 | -2,807 | -14,135 | 221 |
| Investing Cash Flow | $-15,410 | $-14,290 | $-16,686 | $-26,408 | $-27,181 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,330 | 872 | 20,627 | 15,725 | 14,718 |
| Financing Cash Flow | $1,330 | $872 | $20,627 | $15,725 | $14,718 |
| Exchange Rate Effect | -195 | 33 | -385 | -15 | -30 |
| Beginning Cash Position | 25,585 | 25,585 | 21,822 | 21,822 | 21,822 |
| End Cash Position | 20,868 | 20,506 | 25,585 | 11,321 | 11,198 |
| Net Cash Flow | $-4,717 | $-5,079 | $3,763 | $-10,501 | $-10,624 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,558 | 8,306 | 207 | 197 | 1,869 |
| Free Cash Flow | 9,558 | 8,306 | 207 | 197 | 1,869 |